ArticleKidney international reports2021

Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome.

Elias Jatem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.